T1	Participants 482 669	a total of 56,294 men aged 55-74 years were screened with serum prostate specific antigen (PSA) in five countries of the European Randomised Study of Screening for Prostate Cancer (ERSPC)
T2	Participants 747 859	Prostate cancer incidence among 92,142 men randomly allocated to the control arm of the trial was also assessed.